Global Needle Biopsy Market Size, Share, Forecast Report, 2020-2027

A Needle Biopsy is a procedure to extract a sample of cells from the body by inserting a needle in the appropriate sampling site. The extracted tissue is then used for laboratory testing so as to find any abnormality. The market for needle biopsy is growing due to market driving factors such as cancers, infections etc.

The development of ultrasensitive imaging technologies such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) etc. are the market constraints. However the emergence of liquid biopsy is the single largest threat to the future of needle biopsy.

Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023.
Segments:

The global Needle Biopsy Market is segmented on the basis of type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the market has been segmented as tumor, infection, inflammation and others.

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenarios and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global needle biopsy. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest growing region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.

Key players of Global Needle Biopsy Market:

Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.